Esperion Therapeutics Inc
F:0ET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Esperion Therapeutics Inc
F:0ET
|
US |
|
C
|
Clean Energy Fuels Corp
SWB:WIQ
|
US |
|
A
|
Addnode Group AB (publ)
LSE:0GMG
|
SE |
|
B
|
Banco Bradesco SA
F:BREC
|
BR |
|
S
|
Son Ha Sai Gon JSC
VN:SHA
|
VN |
|
V
|
Vonovia SE
F:VNA
|
DE |
|
P
|
Petroleo Brasileiro SA Petrobras
XMUN:PJXC
|
BR |
|
Deutsche Post AG
XETRA:DPW
|
DE |
Wall St Price Targets
0ET Price Targets Summary
Esperion Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 0ET is 8.35 EUR with a low forecast of 2.029 EUR and a high forecast of 18.959 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0ET's stock price target?
Price Target
8.35
EUR
According to Wall Street analysts, the average 1-year price target for 0ET is 8.35 EUR with a low forecast of 2.029 EUR and a high forecast of 18.959 EUR.
What is the Revenue forecast for Esperion Therapeutics Inc?
Projected CAGR
3%
The compound annual growth rate for Revenue over the next 8 years is 3%.
What is the Operating Income forecast for Esperion Therapeutics Inc?
Projected CAGR
28%
The compound annual growth rate for Operating Income over the next 8 years is 28%.
